Ready for your all-in-one single cell sequencing solution?
Contact us

Singleron and DKSH Announce Strategic Partnership to Expand Access to Single Cell Multi-Omics Solutions in Australia and New Zealand

3’

Singapore, 7 January 2026 – Singleron Biotechnologies, a global leader in single cell multi-omics solutions, today announced a strategic partnership with DKSH, a leading distributor of advanced life science products in Australia and New Zealand. With this partnership, DKSH will become the exclusive distributor of Singleron’s innovative single cell multi-omics solutions in Australia and New Zealand.

DKSH will provide Singleron’s comprehensive suite of solutions covering the entire single cell analysis workflow, from tissue dissociation and library preparation to bioinformatics analysis. “We are delighted to work with Singleron to bring their advanced single cell multi-omics solutions to researchers in Australia and New Zealand,” said Dr. Richard Speight, General Manager, Technology, DKSH Australia and New Zealand. “These markets have proven results in life science research, and the accessibility to cutting-edge tools is essential for driving innovation. With Singleron’s unique offerings and tissue preservation solution, we can meet the market’s growing demands and empower researchers to accelerate discoveries in biomedical research.”

 “We are excited to work with DKSH as our exclusive distributor in Australia and New Zealand,” said Dr. Jonathan Scolnick, General Manager, Singleron Biotechnologies APAC. “Working with DKSH has helped fuel our growth in APAC and we appreciate the strong scientific and local expertise that they consistently provide in each country. Together, we aim to equip researchers with the tools they need to unlock the complexities of single cell biology.”

This marks the third collaboration between Singleron Biotechnologies and DKSH. Previously established in South Korea and Thailand, the partnership has now expanded to Australia and New Zealand (ANZ). Through DKSH’s established distribution network and local expertise, Singleron will deliver advanced single-cell solutions to researchers in these regions, supporting the growth of precision medicine and life science research.

About Singleron Biotechnologies

Singleron Biotechnologies advances precision medicine and human health through pioneering single cell multi-omics solutions. Its current product portfolio includes high throughput instruments for automated single cell processing and tissue dissociation, reagents, bioinformatics software, and a comprehensive single cell knowledge base.

Founded in 2018, Singleron operates globally with offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in more than 3,000 laboratories in hospitals, research institutes, and pharmaceutical companies.

About DKSH

For 160 years, DKSH has been delivering growth for companies in Asia and beyond its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024.

Check out our latest news and events

Learn more